arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Boundless Bio, Inc.

BOLD Health Care Biotechnology: Pharmaceutical Preparations
$2.38
▼ -2.7% Today
as of Oct 23, 13:46 ET
Last 30 days -16.90% Sep 14 → Oct 23
$2.26 $2.43 $2.60 $2.76 $2.93 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.45
High
$2.46
Low
$2.38
Volume
$114,063
Avg Vol
$448,142
Mkt Cap
$60M
P/E (TTM)
—
Beta
—
52w High
$3.16
52w Low
$0.96
Div Yield
—
Shares Out
$22M

BOLD earnings at a glance

Boundless Bio, Inc. (BOLD) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Over its last 4 reports the stock rose the next day 0 times and fell 4, moving ±3.7% on average; after the most recent report on May 8, 2026 it moved -5.9%. BOLD beat the consensus EPS estimate in 1 of its last 4 reported quarters. The share price of $2.38 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.96
$3.16
64% of range
Avg surprise (last 4)
-8.1%
Avg reaction (last 4)
-3.7%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-12.27$-9.33$-6.39$-3.45$-0.51 Actual $-9.91Actual $-10.28Actual $-10.71Actual $-12.27Actual $-0.77Actual $-0.74Actual $-0.71Est $-0.68Actual $-0.70Est $-0.75Actual $-0.62Est $-0.53Actual $-0.60Est $-0.51Actual $-1.06 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-24M$-21M$-19M$-17M$-15M Sep 24Sep 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.06 — — — — financials
Fri May 8, 2026Mar/2026 $-0.60 $-0.51 -17.6% +15.5% -5.9% earnings
Wed Nov 5, 2025Sep/2025 $-0.62 $-0.53 -17.0% — -3.1% earnings
Tue Aug 5, 2025Jun/2025 $-0.70 $-0.75 +6.7% — -1.7% earnings
Fri May 9, 2025Mar/2025 $-0.71 $-0.68 -4.4% — -4.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.74 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.77 — — — — financials
Sun Mar 31, 2024Mar 2024 $-12.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $-10.71 — — — — financials
Fri Jun 30, 2023Jun 2023 $-10.28 — — — — financials
Fri Mar 31, 2023Mar 2023 $-9.91 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER —-$0.62

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-24M$-14M—$-15M—$-17M—$-19M
Net income$-24M——$-14M———$-17M
EPS (diluted)$-1.06$-0.60—$-0.62—$-0.71—$-0.74

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$20M$17M$18M$15M—$15M$27M$40M
Inventory————————
Total current assets$74M$95M$110M$120M$130M$140M$154M$170M
Total assets$74M$141M$157M$169M$179M$191M$206M$175M
Long-term debt————————
Total liabilities$8M$55M$58M$59M$57M$55M$56M—
Total equity$66M—$99M$110M——$151M$165M

Implied volatility — last 90 days

No IV snapshots yet for BOLD.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

BOLD earnings FAQ

When is BOLD's next earnings date?

Boundless Bio, Inc. is expected to report on November 4, 2026.

How does BOLD stock usually react to earnings?

Across the last 4 reports the average next-day move was ±3.7%, up 0 times and down 4 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.